European Alt-Protein Funding Rises 56% as Grants and Loans Fill the Venture Gap

Investment in Europe's alt-protein sector increased by 56% in the first half of 2026, with European startups accounting for over three-quarters of the global total. The number of deals decreased, leading to larger investments in fewer companies that stood out among the competition, rather than riding a general wave of enthusiasm. Fermentation companies, particularly those using precision and biomass fermentation, saw significant growth, attracting more grant funding than all other alt-protein categories combined.

Cultivated meat funding remained steady, with the largest investments going to companies nearing market readiness. In contrast, plant-based meat and dairy companies faced a decline in private investment as they moved into a capital-intensive scale-up phase. This shift towards scale-up necessitates a shift from relying solely on venture capital to a blended model of grants, loans, and equity to spread the risk of expansion and attract more private investment.